Tuesday 5 November 2024

The Pharma Letter Podcast — Episode 13 — Is there a data capture crisis in biotech?

Biotechnology
Simon Wentworth
5 April 2022
thepharmaletterpodcast-episode13-1

More on this story...

Biotechnology
The Pharma Letter Podcast — Episode 12 — Mastering the microbiome
9 March 2022
Biotechnology
The Pharma Letter Podcast — Episode 9 — The rise of AI in drug discovery
30 December 2021
Pharmaceutical
The Pharma Letter Podcast — Episode 10 — Will decentralized clinical trials become the new standard?
10 February 2022
Biotechnology
Major entrant in biotech discovery could shake up existing order
6 May 2022


More ones to watch >


Today's issue

Vertex ups guidance again as results exceed estimates
Pharmaceutical
Vertex ups guidance again as results exceed estimates
5 November 2024
Biotechnology
Transgene and ProBioGen join forces on cancer vaccines
5 November 2024
Biotechnology
Nxera Pharma and Antiverse partner on GPCRs
5 November 2024
Pharmaceutical
Positive results for Neurocrine’s Ingrezza in tardive dyskinesia
5 November 2024
Pharmaceutical
Boehringer mental health tie-up worth up to $126.5 million to Broad Institute
4 November 2024
Biotechnology
Frits van Alphen gets Memo CDO job
4 November 2024
Pharmaceutical
FDA accepts Ionis NDA for donidalorsen
4 November 2024

Company Spotlight

A Denmark-headquartered company that currently has a pipeline of three independent endocrinology rare disease product candidates in clinical development and is advancing oncology as its second therapeutic area of focus.




More Features in Biotechnology

Transgene and ProBioGen join forces on cancer vaccines
5 November 2024
Nxera Pharma and Antiverse partner on GPCRs
5 November 2024
Frits van Alphen gets Memo CDO job
4 November 2024
Ascendis and Novo Nordisk sign deal on metabolic and CV diseases
4 November 2024


Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze